HUNTER STENZEL: Open Payments
NPI 1134339278 · COOKEVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,160 in 59 payments from 16 companies in 2025. Trend: 2023 $865 · 2024 $886 · 2025 $1,160
Food & beverage: $1,160
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $246 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $145 |
| Amgen Inc. | 13 | $143 |
| Axsome Therapeutics, Inc. | 3 | $142 |
| Astellas Pharma US Inc | 5 | $112 |
| ABBVIE INC. | 4 | $72 |
| Sage Therapeutics, LLC | 3 | $56 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Lilly USA, LLC | 2 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
Products named: CAPLYTA, OTEZLA, Auvelity, Ozempic, Veozah, Rybelsus, Wegovy, VRAYLAR.
Industry payments across TN — which companies pay providers there.
